Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.

Sridevi, K

Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery. [electronic resource] - International immunopharmacology Nov 2003 - 1589-600 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1567-5769

10.1016/S1567-5769(03)00181-4 doi


Acetylmuramyl-Alanyl-Isoglutamine--analogs & derivatives
Adjuvants, Immunologic--administration & dosage
Ammonium Chloride--pharmacology
Antigen Presentation--immunology
Antigens, Bacterial--administration & dosage
Cell Wall--chemistry
Clonal Anergy--immunology
Culture Media, Conditioned--chemistry
Glutaral--pharmacology
Humans
Interferon-gamma--analysis
Interleukin-10--analysis
Interleukin-2--analysis
Interleukin-4--analysis
Leprosy--immunology
Leukocytes, Mononuclear--immunology
Liposomes
Lymphocyte Activation--drug effects
Mycobacterium leprae--immunology
Mycobacterium tuberculosis--immunology
Peptides--immunology
Sodium Fluoride--pharmacology
T-Lymphocytes--drug effects